About
Leadership
Scientific Advisors
Community Outreach
Careers
Contact Us
Technology
Manufacturing
Publications
Pipeline & Clinical Trials
D-Fi Gene Therapy for Dystrophic EB (DEB)
LV-FAH Gene Therapy
for Hereditary Tyrosinemia
Type 1 (HT1)
Clinical Trials
Patients & Families
Epidermolysis Bullosa EB
Tyrosinemia
Newsroom
Press Releases
Events & Presentations
Media Coverage
Contact Us
Toggle navigation
Leadership
About
Leadership
Rob Kaiser, Ph.D., D.A.B.T
Rob Kaiser, Ph.D., D.A.B.T
Vice President, Pre-Clinical Development
